Moderna, Inc.
A biotechnology company that uses messenger RNA (mRNA) to build medicines and vaccines, best known for Spikevax, its COVID-19 vaccine. Founded in 2010 in Cambridge, Massachusetts, it grew out of the venture-building firm Flagship Pioneering with help from scientists including MIT's Robert Langer. Its name blends "modified" and "RNA"—and conveniently hides the word "modern."
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| Capital World Investors | 13GPassive | 5.6% | 22.28M | Aug 12, 2026 |
| FMR LLC | 13G/APassive | 13.1% | 51.80M | Aug 6, 2026 |
| Abigail P. Johnson | 13G/APassive | 13.1% | 51.80M | Aug 6, 2026 |
| BAILLIE GIFFORD & CO | 13G/APassive | 4.6% | 18.21M | Jul 24, 2026 |
| Vanguard Capital Management | 13GPassive | 6.53% | 25.93M | Apr 30, 2026 |
| The Vanguard Group | 13G/APassive | 0% | 0 | Mar 27, 2026 |